Papers: 9 May 2014 - 16 May 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Validity and reliability of VO2-max measurements in persons with multiple sclerosis. Langeskov-Christensen M, Langeskov-Christensen D, Overgaard K, Møller A B, Dalgas U J Neurol Sci. 2014 Apr 27. PMID: 24825731. Abstract Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review. Martín-Valero R, Zamora-Pascual N, Armenta-Peinado J A Respir Care. 2014 May 13. PMID: 24825913. Abstract Magnetic resonance imaging in neuromyelitis optica. Tackley G, Kuker W, Palace J Mult Scler. 2014 May 14. PMID: 24829291. Abstract Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Esen N, Rainey-Barger EK, Huber AK, Blakely PK, Irani DN Glia. 2014 May 14. PMID: 24829092. Abstract An adverse lipid profile is associated with disability and progression in disability, in people with MS. Tettey P, Simpson S, Taylor B, Blizzard L, Ponsonby A-L, Dwyer T, Kostner K, van der Mei I Mult Scler. 2014 May 14. PMID: 24829292. Abstract IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. Hou W, Jin Y-H, Kang H S, Kim BS J Virol. 2014 May 14. PMID: 24829345. Abstract Correction to: Multiple sclerosis in the Levant: a regional consensus statement. Int J Neurosci. 2014 May 13:1-2. PMID: 24825587. Abstract Alterations of calcium homeostasis in cultured rat astrocytes evoked by bioactive sphingolipids. Stenovec M, Trkov S, Kreft M, Zorec R Acta Physiol (Oxf). 2014 May 13. PMID: 24825022. Abstract Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter Using Susceptibility-based MR Imaging. Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS Radiology. 2014 May 4:132475. PMID: 24828000. Abstract Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis. Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker G-A, Patt M, Thomae E, Seese A, et al. Eur J Nucl Med Mol Imaging. 2014 May 15. PMID: 24827604. Abstract [Diet and multiple sclerosis]. Pozuelo-Moyano B, Benito-Leon J Rev Neurol. 2014 May 16; 58(10):455-64. PMID: 24819942. Abstract Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis: In Search of Biomarkers. Alvermann S, Hennig C, Stüve O, Wiendl H, Stangel M JAMA Neurol. 2014 May 12. PMID: 24818670. Abstract Natalizumab Use During the Third Trimester of Pregnancy. Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, et al. JAMA Neurol. 2014 May 12. PMID: 24821217. Abstract Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation. Bittner S, Ruck T, Göbel K, Henschel C, Afzali A M, Göb E, Müntefering T, Kleinschnitz C, Wiendl H, Meuth SG Am J Pathol. 2014 May 9. PMID: 24819960. Abstract Interferon beta treatment of multiple sclerosis increases serum interleukin-7. Lundström W, Hermanrud C, Sjöstrand M, Brauner S, Wahren-Herlenius M, Olsson T, Karrenbauer V, Hillert J, Fogdell-Hahn A Mult Scler. 2014 May 12. PMID: 24821684. Abstract Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events. Coyle PK, Sinclair SM, Scheuerle AE, Thorp JM, Albano JD, Rametta MJ BMJ Open. 2014; 4(5):e004536. PMID: 24821713. Abstract Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis. Stecková T, Hluštík P, Sládková V, Odstrčil F, Mareš J, Kaňovský P J Neurol Sci. 2014 Apr 30. PMID: 24819917. Abstract Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report. Cresswell M, Buckland J, West P, Sparrow O J Laryngol Otol. 2014 May 12:1-3. PMID: 24819466. Abstract Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2. Okahara K, Kizuka Y, Kitazume S, Ota F, Nakajima K, Hirabayashi Y, Maekawa M, Yoshikawa T, Taniguchi N Glycobiology. 2014 May 11. PMID: 24821492. Abstract Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis. Klawiter EC, Ceccarelli A, Arora A, Jackson J, Bakshi S, Kim G, Miller J, Tauhid S, von Gizycki C, Bakshi R, et al. J Neuroimaging. 2014 May 9. PMID: 24816394. Abstract Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases. Payne NL, Sylvain A, O'Brien C, Herszfeld D, Sun G, Bernard CCA N Biotechnol. 2014 May 9. PMID: 24815224. Abstract Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis. Aydın T, Akif Sarıyıldız M, Guler M, Celebi A, Seyithanoglu H, Mirzayev I, Peru C, Sezer E, Batmaz I Eur Rev Med Pharmacol Sci. 2014 Apr; 18(8):1189-98. PMID: 24817294. Abstract GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone. Paul AM, Branton WG, Walsh JG, Polyak MJ, Lu J-Q, Baker G, Power C Neuroscience. 2014 May 9. PMID: 24814730. Abstract Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients pDC deficit of early response to toll-like receptor 7 agonist stimulation. Mycko MP, Cwiklinska H, Cichalewska M, Matysiak M, Lewkowicz P, Sliwinska B, Selmaj I, Selmaj KW Clin Immunol. 2014 May 9; 153(1):211-219. PMID: 24814238. Abstract Onset symptoms in paediatric multiple sclerosis. Boesen M S, Sellebjerg F, Blinkenberg M Dan Med J. 2014 Apr; 61(4):A4800. PMID: 24814585. Abstract B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients. Rovituso D, Heller S, Schroeter M, Kleinschnitz C, Kuerten S J Neuroimmunol. 2014 Apr 24. PMID: 24814390. Abstract [Coping with multiple sclerosis in partnerships : A systematic review of the literature.] Busch A-K, Spirig R, Schnepp W Nervenarzt. 2014 May 11. PMID: 24817637. Abstract A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification. Machnik G, Labuzek K, Skudrzyk E, Rekowski P, Ruczyński J, Wojciechowska M, Mucha P, Giri S, Okopień B Mol Cell Probes. 2014 May 9. PMID: 24814867. Abstract Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. Wang X, Cusick MF, Wang Y, Sun P, Libbey JE, Trinkaus K, Fujinami RS, Song S-K NMR Biomed. 2014 May 12. PMID: 24816651. Abstract Role of vitamin D in acquired immune and autoimmune diseases. Delvin E, Souberbielle J-C, Viard J-P, Salle B Crit Rev Clin Lab Sci. 2014 May 9. PMID: 24813330. Abstract SNPsea: an algorithm to identify cell types, tissues, and pathways affected by risk loci. Slowikowski K, Hu X, Raychaudhuri S Bioinformatics. 2014 May 10. PMID: 24813542. Abstract The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo. Klein R, Blaschke S, Neumaier B, Endepols H, Graf R, Keuters M, Hucklenbroich J, Albrechtsen M, Rees S, Fink G R, et al. Stem Cell Rev. 2014 May 10. PMID: 24817672. Abstract Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis. Kalman B, Toldy E Neuromolecular Med. 2014 May 10. PMID: 24817688. Abstract Miscellaneous indications for extracorporeal photochemotherapy (ECP). Andreu-Ullrich H Transfus Apher Sci. 2014 Apr 13. PMID: 24816437. Abstract Neural correlates of alerting and orienting impairment in multiple sclerosis patients. Vázquez-Marrufo M, Galvao-Carmona A, González-Rosa JJ, Hidalgo-Muñoz AR, Borges M, Ruiz-Peña J L, Izquierdo G PLoS One. 2014; 9(5):e97226. Epub 2014 May 12. PMID: 24820333. Abstract Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality. Marrie R A, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A Neurology. 2014 May 7. PMID: 24808019. Abstract Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease. Kamat PK, Kalani A, Kyles P, Tyagi SC, Tyagi N Cell Biochem Biophys. 2014 May 8. PMID: 24807843. Abstract The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple scl Barkhof F, de Jong R, Sfikas N, de Vera A, Francis G, Cohen J, on behalf of the TRANSFORMS study group Mult Scler. 2014 May 8. PMID: 24812043. Abstract Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. Nam Y, Kim J-H, Seo M, Kim J-H, Jin M, Jeon S, Seo J-W, Lee W-H, Bing S J, Jee Y, et al. J Biol Chem. 2014 May 7. PMID: 24808182. Abstract Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells. Bergsland M, Covacu R, Perez Estrada C, Svensson M, Brundin L Stem Cells. 2014 May 8. PMID: 24807147. Abstract Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis. Weiler S, Braendlin N, Beerli C, Bergsdorf C, Schubart A, Srinivas H, Oberhauser B, Billich A J Med Chem. 2014 May 8. PMID: 24809814. Abstract Postural orthostatic tachycardia syndrome: additional phenotypic feature of neuromyelitis optica spectrum disorder. Barun B, Adamec I, Lovrić M, Habek M Neurol Sci. 2014 May 8. PMID: 24807235. Abstract PET imaging in multiple sclerosis. de Paula Faria D, Copray S, Buchpiguel C, Dierckx R, de Vries E J Neuroimmune Pharmacol. 2014 May 9. PMID: 24809810. Abstract Identifying environmental antigens that activate myelin-specific T cells. Stadinski BD, Huseby ES Trends Immunol. 2014 Jun; 35(6):231-2. Epub 2014 May 09. PMID: 24820694. Abstract Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey. Patti F, Vila C Neuroepidemiology. 2014 May 7; 42(4):211-218. Epub 2014 May 07. PMID: 24821493. Abstract Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain. Rodríguez-Antigüedad Zarranz A, Mendibe Bilbao M, Llarena González C, Audicana C Neuroepidemiology. 2014 May 7; 42(4):219-225. Epub 2014 May 07. PMID: 24821604. Abstract Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Khalili M, Azimi A R, Izadi V, Eghtesadi S, Mirshafiey A, Sahraian M A, Motevalian A, Norouzi A, Sanoobar M, Eskandari G, et al. Neuroimmunomodulation. 2014 May 6. Epub 2014 May 06. PMID: 24821457. Abstract KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis. Wunsch M, Rovituso DM, Kuerten S Front Neurol. 2014; 5:62. Epub 2014 Apr 30. PMID: 24817862. Abstract Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire. Huh S-Y, Joo J, Kim S-H, Joung A-R, Park K, Kim W, Park M S, Kim H J J Clin Neurol. 2014 Apr; 10(2):148-56. Epub 2014 Apr 23. PMID: 24829601. Abstract Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding. Cabezas M, Oliver A, Roura E, Freixenet J, Vilanova JC, Ramió-Torrentà L, Rovira A, Lladó X Comput Methods Programs Biomed. 2014 Jul; 115(3):147-61. Epub 2014 Apr 19. PMID: 24813718. Abstract Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose. Ballesta Méndez M, van Pesch V, Capron A, Hantson P Case Rep Neurol Med. 2014; 2014:237064. Epub 2014 Apr 17. PMID: 24822136. Abstract The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis. Zivković M, Starčević Čizmarević N, Lovrečić L, Klupka-Sarić I, Stanković A, Gašparović I, Lavtar P, Dinčić E, Stojković L, Rudolf G, et al. Dis Markers. 2014; 2014:362708. Epub 2014 Apr 16. PMID: 24825926. Abstract Determinants of disability in multiple sclerosis: an immunological and MRI study. Tortorella P, Laganà M M, Saresella M, Tavazzi E, Preti M G, Ricci C, Baglio F, Marventano I, Piancone F, Baselli G, et al. Biomed Res Int. 2014; 2014:875768. Epub 2014 Apr 09. PMID: 24818159. Abstract Bipolar disorder and multiple sclerosis: a case series. Sidhom Y, Djebara M B, Hizem Y, Abdelkefi I, Kacem I, Gargouri A, Gouider R Behav Neurol. 2014; 2014:536503. Epub 2014 Mar 17. PMID: 24825960. Abstract Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy. Milosevic Z, Tanic N, Bankovic J, Stankovic T, Buta M, Lavrnic D, Milovanovic Z, Pupic G, Stojkovic S, Milinkovic V, et al. Int J Clin Exp Pathol. 2014; 7(4):1826-33. Epub 2014 Mar 15. PMID: 24817989. Abstract Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring. Kolodziej MA, Proemmel P, Quint K, Strik HM Neurol Neurochir Pol. 2014 Mar-Apr; 48(2):116-21. Epub 2014 Jan 23. PMID: 24821637. Abstract The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients. Podlecka-Piętowska A, Kochanowski J, Zakrzewska-Pniewska B, Opolski G, Kwieciński H, Kamińska A M Neurol Neurochir Pol. 2014 Mar-Apr; 48(2):111-5. Epub 2014 Jan 23. PMID: 24821636. Abstract LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS. Roy S, Carass A, Shiee N, Pham DL, Calabresi P, Reich D, Prince JL Proc IEEE Int Symp Biomed Imaging. 2013:1384-1387. PMID: 24816891. Abstract Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al. Delbue S, Guerini F R, Mancuso R, Caputo D, Mazziotti R, Saresella M, Ferrante P J Neurovirol. 2008 Jan; 14(1):87-88. PMID: 24817821. Abstract
Validity and reliability of VO2-max measurements in persons with multiple sclerosis. Langeskov-Christensen M, Langeskov-Christensen D, Overgaard K, Møller A B, Dalgas U J Neurol Sci. 2014 Apr 27. PMID: 24825731. Abstract
Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review. Martín-Valero R, Zamora-Pascual N, Armenta-Peinado J A Respir Care. 2014 May 13. PMID: 24825913. Abstract
Magnetic resonance imaging in neuromyelitis optica. Tackley G, Kuker W, Palace J Mult Scler. 2014 May 14. PMID: 24829291. Abstract
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Esen N, Rainey-Barger EK, Huber AK, Blakely PK, Irani DN Glia. 2014 May 14. PMID: 24829092. Abstract
An adverse lipid profile is associated with disability and progression in disability, in people with MS. Tettey P, Simpson S, Taylor B, Blizzard L, Ponsonby A-L, Dwyer T, Kostner K, van der Mei I Mult Scler. 2014 May 14. PMID: 24829292. Abstract
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. Hou W, Jin Y-H, Kang H S, Kim BS J Virol. 2014 May 14. PMID: 24829345. Abstract
Correction to: Multiple sclerosis in the Levant: a regional consensus statement. Int J Neurosci. 2014 May 13:1-2. PMID: 24825587. Abstract
Alterations of calcium homeostasis in cultured rat astrocytes evoked by bioactive sphingolipids. Stenovec M, Trkov S, Kreft M, Zorec R Acta Physiol (Oxf). 2014 May 13. PMID: 24825022. Abstract
Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter Using Susceptibility-based MR Imaging. Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS Radiology. 2014 May 4:132475. PMID: 24828000. Abstract
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis. Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker G-A, Patt M, Thomae E, Seese A, et al. Eur J Nucl Med Mol Imaging. 2014 May 15. PMID: 24827604. Abstract
[Diet and multiple sclerosis]. Pozuelo-Moyano B, Benito-Leon J Rev Neurol. 2014 May 16; 58(10):455-64. PMID: 24819942. Abstract
Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis: In Search of Biomarkers. Alvermann S, Hennig C, Stüve O, Wiendl H, Stangel M JAMA Neurol. 2014 May 12. PMID: 24818670. Abstract
Natalizumab Use During the Third Trimester of Pregnancy. Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, et al. JAMA Neurol. 2014 May 12. PMID: 24821217. Abstract
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation. Bittner S, Ruck T, Göbel K, Henschel C, Afzali A M, Göb E, Müntefering T, Kleinschnitz C, Wiendl H, Meuth SG Am J Pathol. 2014 May 9. PMID: 24819960. Abstract
Interferon beta treatment of multiple sclerosis increases serum interleukin-7. Lundström W, Hermanrud C, Sjöstrand M, Brauner S, Wahren-Herlenius M, Olsson T, Karrenbauer V, Hillert J, Fogdell-Hahn A Mult Scler. 2014 May 12. PMID: 24821684. Abstract
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events. Coyle PK, Sinclair SM, Scheuerle AE, Thorp JM, Albano JD, Rametta MJ BMJ Open. 2014; 4(5):e004536. PMID: 24821713. Abstract
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis. Stecková T, Hluštík P, Sládková V, Odstrčil F, Mareš J, Kaňovský P J Neurol Sci. 2014 Apr 30. PMID: 24819917. Abstract
Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report. Cresswell M, Buckland J, West P, Sparrow O J Laryngol Otol. 2014 May 12:1-3. PMID: 24819466. Abstract
Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2. Okahara K, Kizuka Y, Kitazume S, Ota F, Nakajima K, Hirabayashi Y, Maekawa M, Yoshikawa T, Taniguchi N Glycobiology. 2014 May 11. PMID: 24821492. Abstract
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis. Klawiter EC, Ceccarelli A, Arora A, Jackson J, Bakshi S, Kim G, Miller J, Tauhid S, von Gizycki C, Bakshi R, et al. J Neuroimaging. 2014 May 9. PMID: 24816394. Abstract
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases. Payne NL, Sylvain A, O'Brien C, Herszfeld D, Sun G, Bernard CCA N Biotechnol. 2014 May 9. PMID: 24815224. Abstract
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis. Aydın T, Akif Sarıyıldız M, Guler M, Celebi A, Seyithanoglu H, Mirzayev I, Peru C, Sezer E, Batmaz I Eur Rev Med Pharmacol Sci. 2014 Apr; 18(8):1189-98. PMID: 24817294. Abstract
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone. Paul AM, Branton WG, Walsh JG, Polyak MJ, Lu J-Q, Baker G, Power C Neuroscience. 2014 May 9. PMID: 24814730. Abstract
Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients pDC deficit of early response to toll-like receptor 7 agonist stimulation. Mycko MP, Cwiklinska H, Cichalewska M, Matysiak M, Lewkowicz P, Sliwinska B, Selmaj I, Selmaj KW Clin Immunol. 2014 May 9; 153(1):211-219. PMID: 24814238. Abstract
Onset symptoms in paediatric multiple sclerosis. Boesen M S, Sellebjerg F, Blinkenberg M Dan Med J. 2014 Apr; 61(4):A4800. PMID: 24814585. Abstract
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients. Rovituso D, Heller S, Schroeter M, Kleinschnitz C, Kuerten S J Neuroimmunol. 2014 Apr 24. PMID: 24814390. Abstract
[Coping with multiple sclerosis in partnerships : A systematic review of the literature.] Busch A-K, Spirig R, Schnepp W Nervenarzt. 2014 May 11. PMID: 24817637. Abstract
A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification. Machnik G, Labuzek K, Skudrzyk E, Rekowski P, Ruczyński J, Wojciechowska M, Mucha P, Giri S, Okopień B Mol Cell Probes. 2014 May 9. PMID: 24814867. Abstract
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. Wang X, Cusick MF, Wang Y, Sun P, Libbey JE, Trinkaus K, Fujinami RS, Song S-K NMR Biomed. 2014 May 12. PMID: 24816651. Abstract
Role of vitamin D in acquired immune and autoimmune diseases. Delvin E, Souberbielle J-C, Viard J-P, Salle B Crit Rev Clin Lab Sci. 2014 May 9. PMID: 24813330. Abstract
SNPsea: an algorithm to identify cell types, tissues, and pathways affected by risk loci. Slowikowski K, Hu X, Raychaudhuri S Bioinformatics. 2014 May 10. PMID: 24813542. Abstract
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo. Klein R, Blaschke S, Neumaier B, Endepols H, Graf R, Keuters M, Hucklenbroich J, Albrechtsen M, Rees S, Fink G R, et al. Stem Cell Rev. 2014 May 10. PMID: 24817672. Abstract
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis. Kalman B, Toldy E Neuromolecular Med. 2014 May 10. PMID: 24817688. Abstract
Miscellaneous indications for extracorporeal photochemotherapy (ECP). Andreu-Ullrich H Transfus Apher Sci. 2014 Apr 13. PMID: 24816437. Abstract
Neural correlates of alerting and orienting impairment in multiple sclerosis patients. Vázquez-Marrufo M, Galvao-Carmona A, González-Rosa JJ, Hidalgo-Muñoz AR, Borges M, Ruiz-Peña J L, Izquierdo G PLoS One. 2014; 9(5):e97226. Epub 2014 May 12. PMID: 24820333. Abstract
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality. Marrie R A, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A Neurology. 2014 May 7. PMID: 24808019. Abstract
Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease. Kamat PK, Kalani A, Kyles P, Tyagi SC, Tyagi N Cell Biochem Biophys. 2014 May 8. PMID: 24807843. Abstract
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple scl Barkhof F, de Jong R, Sfikas N, de Vera A, Francis G, Cohen J, on behalf of the TRANSFORMS study group Mult Scler. 2014 May 8. PMID: 24812043. Abstract
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. Nam Y, Kim J-H, Seo M, Kim J-H, Jin M, Jeon S, Seo J-W, Lee W-H, Bing S J, Jee Y, et al. J Biol Chem. 2014 May 7. PMID: 24808182. Abstract
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells. Bergsland M, Covacu R, Perez Estrada C, Svensson M, Brundin L Stem Cells. 2014 May 8. PMID: 24807147. Abstract
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis. Weiler S, Braendlin N, Beerli C, Bergsdorf C, Schubart A, Srinivas H, Oberhauser B, Billich A J Med Chem. 2014 May 8. PMID: 24809814. Abstract
Postural orthostatic tachycardia syndrome: additional phenotypic feature of neuromyelitis optica spectrum disorder. Barun B, Adamec I, Lovrić M, Habek M Neurol Sci. 2014 May 8. PMID: 24807235. Abstract
PET imaging in multiple sclerosis. de Paula Faria D, Copray S, Buchpiguel C, Dierckx R, de Vries E J Neuroimmune Pharmacol. 2014 May 9. PMID: 24809810. Abstract
Identifying environmental antigens that activate myelin-specific T cells. Stadinski BD, Huseby ES Trends Immunol. 2014 Jun; 35(6):231-2. Epub 2014 May 09. PMID: 24820694. Abstract
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey. Patti F, Vila C Neuroepidemiology. 2014 May 7; 42(4):211-218. Epub 2014 May 07. PMID: 24821493. Abstract
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain. Rodríguez-Antigüedad Zarranz A, Mendibe Bilbao M, Llarena González C, Audicana C Neuroepidemiology. 2014 May 7; 42(4):219-225. Epub 2014 May 07. PMID: 24821604. Abstract
Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Khalili M, Azimi A R, Izadi V, Eghtesadi S, Mirshafiey A, Sahraian M A, Motevalian A, Norouzi A, Sanoobar M, Eskandari G, et al. Neuroimmunomodulation. 2014 May 6. Epub 2014 May 06. PMID: 24821457. Abstract
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis. Wunsch M, Rovituso DM, Kuerten S Front Neurol. 2014; 5:62. Epub 2014 Apr 30. PMID: 24817862. Abstract
Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire. Huh S-Y, Joo J, Kim S-H, Joung A-R, Park K, Kim W, Park M S, Kim H J J Clin Neurol. 2014 Apr; 10(2):148-56. Epub 2014 Apr 23. PMID: 24829601. Abstract
Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding. Cabezas M, Oliver A, Roura E, Freixenet J, Vilanova JC, Ramió-Torrentà L, Rovira A, Lladó X Comput Methods Programs Biomed. 2014 Jul; 115(3):147-61. Epub 2014 Apr 19. PMID: 24813718. Abstract
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose. Ballesta Méndez M, van Pesch V, Capron A, Hantson P Case Rep Neurol Med. 2014; 2014:237064. Epub 2014 Apr 17. PMID: 24822136. Abstract
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis. Zivković M, Starčević Čizmarević N, Lovrečić L, Klupka-Sarić I, Stanković A, Gašparović I, Lavtar P, Dinčić E, Stojković L, Rudolf G, et al. Dis Markers. 2014; 2014:362708. Epub 2014 Apr 16. PMID: 24825926. Abstract
Determinants of disability in multiple sclerosis: an immunological and MRI study. Tortorella P, Laganà M M, Saresella M, Tavazzi E, Preti M G, Ricci C, Baglio F, Marventano I, Piancone F, Baselli G, et al. Biomed Res Int. 2014; 2014:875768. Epub 2014 Apr 09. PMID: 24818159. Abstract
Bipolar disorder and multiple sclerosis: a case series. Sidhom Y, Djebara M B, Hizem Y, Abdelkefi I, Kacem I, Gargouri A, Gouider R Behav Neurol. 2014; 2014:536503. Epub 2014 Mar 17. PMID: 24825960. Abstract
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy. Milosevic Z, Tanic N, Bankovic J, Stankovic T, Buta M, Lavrnic D, Milovanovic Z, Pupic G, Stojkovic S, Milinkovic V, et al. Int J Clin Exp Pathol. 2014; 7(4):1826-33. Epub 2014 Mar 15. PMID: 24817989. Abstract
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring. Kolodziej MA, Proemmel P, Quint K, Strik HM Neurol Neurochir Pol. 2014 Mar-Apr; 48(2):116-21. Epub 2014 Jan 23. PMID: 24821637. Abstract
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients. Podlecka-Piętowska A, Kochanowski J, Zakrzewska-Pniewska B, Opolski G, Kwieciński H, Kamińska A M Neurol Neurochir Pol. 2014 Mar-Apr; 48(2):111-5. Epub 2014 Jan 23. PMID: 24821636. Abstract
LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS. Roy S, Carass A, Shiee N, Pham DL, Calabresi P, Reich D, Prince JL Proc IEEE Int Symp Biomed Imaging. 2013:1384-1387. PMID: 24816891. Abstract
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al. Delbue S, Guerini F R, Mancuso R, Caputo D, Mazziotti R, Saresella M, Ferrante P J Neurovirol. 2008 Jan; 14(1):87-88. PMID: 24817821. Abstract